Search





Search





Markets
/
Stocks
/
howl
/

Werewolf Therapeutics Inc

HOWL

Add to Watchlist

0.353USD

-0.147-29.44%

Close 07-31 16:00（ET）Quotes delayed by 15 min

17.16MMarket Cap

LossP/E TTM

Werewolf Therapeutics Inc

0.353

-0.147-29.44%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

HOWL Cash Flow Statement

You can access the annual and quarterly cash flow statements of Werewolf Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

143.72%6.63M

44.07%-10.60M

22.65%-11.02M

-21.62%-15.16M

-6.96%-15.16M

-23.87%-18.95M

-210.84%-14.25M

-72.89%-12.46M

-29.81%-14.18M

-54.55%-15.30M

61.37%-4.58M

50.19%-7.21M

-3504.29%-10.92M

29.05%-9.90M

6.34%-11.87M

-16.55%-14.47M

97.10%-303.00K

-90.43%-13.95M

-110.90%-12.67M

-152.33%-12.42M

---10.46M

---7.33M

---6.01M

---4.92M

Net income from continuing operations

120.41%3.67M

25.19%-13.53M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-69.96%-20.40M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

-0.61%-12.00M

30.63%-8.29M

65.07%-5.10M

21.91%-11.98M

33.24%-11.93M

13.19%-11.94M

-33.63%-14.59M

-106.36%-15.34M

-141.41%-17.87M

-126.73%-13.76M

---10.92M

---7.43M

---7.40M

---6.07M

Operating gains losses

503.94%2.45M

-6.57%398.00K

-9.50%400.00K

-11.45%402.00K

-10.57%406.00K

-8.19%426.00K

-3.91%442.00K

2.02%454.00K

4.61%454.00K

9.18%464.00K

10.31%460.00K

10.15%445.00K

134.59%434.00K

333.67%425.00K

768.75%417.00K

502.99%404.00K

198.39%185.00K

151.28%98.00K

9.09%48.00K

63.41%67.00K

--62.00K

--39.00K

--44.00K

--41.00K

Other non-cash items

-645.60%-1.05M

15.96%218.00K

16.38%206.00K

17.16%198.00K

-73.12%193.00K

-50.00%188.00K

-51.24%177.00K

-68.53%169.00K

111.80%718.00K

-5.05%376.00K

5.52%363.00K

76.64%537.00K

-41.35%339.00K

3.39%396.00K

3027.27%344.00K

76.74%304.00K

240.00%578.00K

130.72%383.00K

-96.55%11.00K

--172.00K

--170.00K

--166.00K

--319.00K

--0.00

Change in working capital

-3253.33%-2.52M

138.68%1.47M

-204.53%-3.19M

-193.17%-1.15M

-112.73%-75.00K

-62.24%-3.80M

-34.15%3.05M

158.78%1.23M

106.85%589.00K

-1536.20%-2.34M

256.84%4.63M

59.51%-2.09M

-174.82%-8.60M

119.54%163.00K

-176.85%-2.95M

-1269.76%-5.16M

2181.34%11.49M

-31.34%-834.00K

374.78%3.84M

-138.75%-377.00K

---552.00K

---635.00K

--809.00K

--973.00K

-Change in receivables

----

-100.00%0.00

-89.83%464.00K

-92.03%81.00K

134.23%230.00K

-14.56%575.00K

273.55%4.56M

148.85%1.02M

69.73%-672.00K

--673.00K

---2.63M

---2.08M

---2.22M

----

-Change in prepaid expenses

167.38%475.00K

22.90%161.00K

493.25%967.00K

-53.37%457.00K

40.15%-705.00K

-81.39%131.00K

-75.71%163.00K

467.04%980.00K

-103.10%-1.18M

-51.21%704.00K

-76.51%671.00K

60.27%-267.00K

87.15%-580.00K

-19.34%1.44M

522.44%2.86M

20.00%-672.00K

-62.88%-4.51M

2108.64%1.79M

339.06%459.00K

-2000.00%-840.00K

---2.77M

--81.00K

---192.00K

---40.00K

-Change in other current assets

----

-341.91%-329.00K

1727.78%329.00K

----

-109.17%-136.00K

6700.00%136.00K

101.49%18.00K

---18.00K

328.51%1.48M

--2.00K

---1.21M

----

---649.00K

----

-Change in other current liabilities

----

--0.00

100.00%0.00

-100.00%0.00

68.14%-933.00K

83.94%-407.00K

72.27%-871.00K

100.57%13.00K

-122.08%-2.93M

---2.53M

---3.14M

---2.27M

16472.84%13.26M

-100.00%0.00

100.00%0.00

---81.00K

--50.00K

--31.00K

---9.00K

Cash from non-recurring investing activities

Cash from operating activities

143.72%6.63M

44.07%-10.60M

22.65%-11.02M

-21.62%-15.16M

-6.96%-15.16M

-23.87%-18.95M

-210.84%-14.25M

-72.89%-12.46M

-29.81%-14.18M

-54.55%-15.30M

61.37%-4.58M

50.19%-7.21M

-3504.29%-10.92M

29.05%-9.90M

6.34%-11.87M

-16.55%-14.47M

97.10%-303.00K

-90.43%-13.95M

-110.90%-12.67M

-152.33%-12.42M

---10.46M

---7.33M

---6.01M

---4.92M

Investing cash flow

Net cash from continuing investing activities

---416.00K

----

-100.00%0.00

-37.88%123.00K

-98.64%3.00K

-90.66%17.00K

-33.93%111.00K

-61.78%198.00K

-88.69%221.00K

-83.62%182.00K

500.00%168.00K

90.44%518.00K

1815.69%1.95M

900.90%1.11M

115.38%28.00K

2922.22%272.00K

78.95%102.00K

--111.00K

--13.00K

--9.00K

--57.00K

Capital expenditures

----

-100.00%0.00

-37.88%123.00K

-98.64%3.00K

-90.66%17.00K

-33.93%111.00K

-61.78%198.00K

-88.69%221.00K

-83.62%182.00K

500.00%168.00K

90.44%518.00K

1815.69%1.95M

900.90%1.11M

115.38%28.00K

2922.22%272.00K

78.95%102.00K

--111.00K

--13.00K

--9.00K

--57.00K

Net cash flow from disposal of fixed assets

---416.00K

----

-100.00%0.00

-37.88%123.00K

-98.64%3.00K

-90.66%17.00K

-33.93%111.00K

-61.78%198.00K

-88.69%221.00K

-83.62%182.00K

500.00%168.00K

90.44%518.00K

1815.69%1.95M

900.90%1.11M

115.38%28.00K

2922.22%272.00K

78.95%102.00K

--111.00K

--13.00K

--9.00K

--57.00K

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

----

100.00%0.00

37.88%-123.00K

98.64%-3.00K

90.66%-17.00K

33.93%-111.00K

61.78%-198.00K

88.69%-221.00K

83.62%-182.00K

-500.00%-168.00K

-90.44%-518.00K

-1815.69%-1.95M

-900.90%-1.11M

-115.38%-28.00K

-2922.22%-272.00K

-78.95%-102.00K

---111.00K

---13.00K

---9.00K

---57.00K

Financing cash flow

Cash flow from continuous financing activities

----

-7.11%2.37M

54666.67%3.27M

103.99%388.00K

-100.00%0.00

-71.93%2.55M

-114.63%-6.00K

-1504.62%-9.72M

-58.33%20.26M

622.37%9.07M

-99.63%41.00K

-79.74%692.00K

30480.50%48.62M

3205.26%1.26M

4113.04%11.08M

-96.90%3.42M

129.55%159.00K

-99.95%38.00K

-184.54%-276.00K

--110.20M

---538.00K

--71.88M

---97.00K

Net cash flow from debt Issuance/repayment

----

--0.00

----

--0.00

---10.00M

-100.00%0.00

--0.00

--40.00M

----

Net cash flow from common stock issuance/repurchase

----

-6.57%2.32M

11389.66%3.27M

-60.43%347.00K

-100.00%0.00

-72.07%2.48M

-149.15%-29.00K

29.93%877.00K

132.38%20.25M

521.12%8.88M

-99.47%59.00K

-81.52%675.00K

--8.71M

--1.43M

--11.11M

-96.73%3.65M

----

--0.00

--111.60M

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

----

--72.07M

--0.00

Proceeds from stock option exercised by employees

----

-27.27%48.00K

-100.00%0.00

-46.05%41.00K

-100.00%0.00

37.50%66.00K

1050.00%23.00K

52.00%76.00K

--12.00K

100.00%48.00K

-97.14%2.00K

4900.00%50.00K

-100.00%0.00

-7.69%24.00K

159.26%70.00K

-99.24%1.00K

657.14%159.00K

23.81%26.00K

440.00%27.00K

--131.00K

--21.00K

--5.00K

Net cash flow from other financing activities

----

--0.00

----

-100.00%0.00

100.00%0.00

-1939.39%-673.00K

----

172.22%143.00K

80.39%-20.00K

86.19%-33.00K

---90.00K

-1750.00%-198.00K

66.34%-102.00K

84.36%-239.00K

100.00%0.00

105.69%12.00K

-197.06%-303.00K

---1.53M

---559.00K

---211.00K

---102.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

----

-7.11%2.37M

54666.67%3.27M

103.99%388.00K

-100.00%0.00

-71.93%2.55M

-114.63%-6.00K

-1504.62%-9.72M

-58.33%20.26M

622.37%9.07M

-99.63%41.00K

-79.74%692.00K

30480.50%48.62M

3205.26%1.26M

4113.04%11.08M

-96.90%3.42M

129.55%159.00K

-99.95%38.00K

-184.54%-276.00K

--110.20M

---538.00K

--71.88M

---97.00K

Net cash flow

Beginning cash balance

----

-48.36%57.95M

-46.30%66.61M

-42.50%78.49M

-41.86%93.27M

-27.87%112.22M

-18.01%124.04M

-13.97%136.51M

-5.12%160.43M

19.19%155.58M

6.80%151.29M

7.93%158.68M

16.60%169.09M

-17.82%130.53M

-17.51%141.66M

-20.33%147.01M

70.80%145.01M

71.20%158.83M

538.07%171.74M

476.84%184.53M

--84.90M

--92.78M

--26.91M

--31.99M

Current period cash flow changes

-71.68%-25.37M

44.07%-10.60M

26.80%-8.66M

4.72%-11.88M

38.21%-14.78M

-490.60%-18.95M

-375.71%-11.83M

-68.80%-12.47M

-129.70%-23.91M

-87.42%4.85M

138.54%4.29M

-38.09%-7.39M

-620.29%-10.41M

378.99%38.56M

13.75%-11.13M

58.19%-5.35M

-97.99%2.00M

-75.45%-13.82M

-119.60%-12.91M

-152.12%-12.79M

--99.63M

---7.88M

--65.86M

---5.08M

Ending cash balance

-71.99%21.99M

-49.23%47.35M

-48.36%57.95M

-46.30%66.61M

-42.50%78.49M

-41.86%93.27M

-27.87%112.22M

-18.01%124.04M

-13.97%136.51M

-5.12%160.43M

19.19%155.58M

6.80%151.29M

7.93%158.68M

16.60%169.09M

-17.82%130.53M

-17.51%141.66M

-20.33%147.01M

70.80%145.01M

71.20%158.83M

538.07%171.74M

--184.53M

--84.90M

--92.78M

--26.91M

Free cash flow

----

23.31%-11.02M

-21.59%-15.16M

-6.83%-15.16M

-22.98%-18.95M

-200.54%-14.38M

-67.79%-12.46M

-27.84%-14.19M

-53.07%-15.41M

61.39%-4.78M

54.77%-7.43M

-685.22%-11.10M

27.99%-10.07M

4.30%-12.39M

-31.21%-16.43M

86.62%-1.41M

-90.48%-13.98M

-115.10%-12.95M

-151.49%-12.52M

---10.57M

---7.34M

---6.02M

---4.98M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Werewolf Therapeutics Inc Generate?



Werewolf Therapeutics Inc generated -60.29M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Werewolf Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Werewolf Therapeutics Inc's operating cash flow increased by -7.30% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Werewolf Therapeutics Inc's Financing Cash Flow Changed?



Werewolf Therapeutics Inc used 6.03M in financing activities in the latest quarter.

What is free cash flow and why does it matter for HOWL?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Werewolf Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -60.29M reflecting a -6.82% change from the previous year.